The comparisons of S100A8 and S100A9 genes in normal control and different RCC tumor T stages indicated that with T stage progression, the upregulation of S100A8 and S100A9 genes increased (Fig. 4 and Table IV A). This evidence concerns the gene S100A8 and neoplasm.